This year marks an important milestone for BAP Pharma as we celebrate 15 years since the company was founded in 2011 by Dr. Bashir Parkar. Over that time, the company has grown from a specialist provider into a trusted global partner supporting clinical trials and medicines access programmes around the world.
While the business has evolved significantly, the core principle that underpins BAP Pharma has remained the same: a commitment to delivering on our promises.
A Journey of Growth
BAP Pharma’s journey over the past 15 years reflects both ambition and the growing need for reliable partners in the clinical trial supply chain.
Following its founding in the UK, the company expanded internationally with the opening of its US office in New Jersey in 2015, followed by the establishment of BAP Pharma GmbH in Germany in 2020. These milestones strengthened BAP Pharma’s ability to support global clinical trials and provide services closer to customers and patients.
During this period, the organisation also broadened its capabilities, evolving into a fully integrated partner offering services across:
• Comparator sourcing
• Clinical secondary packaging and labelling
• Medicines access programmes
• Global storage and distribution
Together, these services enable BAP Pharma to support pharmaceutical and biotech companies across the full lifecycle of drug development and access.
Supporting Patients and Partners Worldwide
Clinical trials and early access programmes are complex, highly regulated and increasingly global. Ensuring the reliable sourcing, packaging and distribution of medicines requires deep expertise, regulatory understanding and operational precision.
BAP Pharma operates within a tightly regulated environment and works closely with global regulatory authorities to maintain the highest standards of quality, compliance and supply chain integrity.
With facilities in the UK, Germany and the United States, and a global distribution network that supports programmes in more than 100 countries, BAP Pharma helps its partners navigate complexity and deliver treatments to patients safely and efficiently.
At its heart, BAP Pharma’s role is simple but vital: helping to remove uncertainty from clinical trial supply and medicines access.
Built on Expertise and Partnership
Behind BAP Pharma’s success is the dedication of its people and the strength of its partnerships
Over the past 15 years, the company has worked alongside pharmaceutical and biotechnology organisations across a wide range of therapy areas, building trusted relationships based on transparency, collaboration and reliability.
As a specialist provider, BAP Pharma combines global capabilities with the agility and responsiveness that customers value when navigating complex clinical supply chains.
Looking to the Future
Reaching a 15-year milestone is an opportunity to reflect on the journey so far, but it is also a moment to look ahead.
BAP Pharma continues to invest in expanding its capabilities, strengthening global partnerships and supporting the evolving needs of clinical trials and patient access programmes worldwide.
As the company continues to grow, one thing will remain constant — the commitment to delivering on our promises.
Thank You
We would like to thank our employees, customers and partners who have contributed to BAP Pharma’s success over the past 15 years.
Your trust, collaboration and support have made this journey possible, and we look forward to continuing to work together to deliver clinical trials and access to medicines around the world.
